Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Acta Med Litu ; 31(1): 33-36, 2024.
Article in English | MEDLINE | ID: mdl-38978861

ABSTRACT

A 19-year-old female, known case of bipolar disorder had history of amenorrhea (absence of menstruation) for three years. While other causes of amenorrhea such as CNS, pregnancy, other medications, and thyroid issues were ruled out, she was found to have hyper-prolactinemia. Although antipsychotic medications are known to cause amenorrhea due to dopamine receptor blockade, which may result in hyperprolactinemia, the patient's symptoms began before she started these medications. Only drug that she was on for long period is lithium. Current literature shows mixed evidence about lithium's impact on prolactin levels, which can affect menstruation. This case may represent the first report of lithium causing amenorrhea through elevated prolactin levels. Clinicians should be aware of this potential side effect and monitor patients accordingly. Further studies are needed to confirm and understand this potential link.

2.
Indian J Psychiatry ; 61(4): 421-422, 2019.
Article in English | MEDLINE | ID: mdl-31391650
3.
Indian J Med Res ; 135: 184-92, 2012.
Article in English | MEDLINE | ID: mdl-22446860

ABSTRACT

BACKGROUND & OBJECTIVES: High prevalence and poor control of asthma make its management a major public health issue worldwide, especially in developing countries. Optimum review of asthma management in the community is essential to improve asthma control. This study was conducted to investigate the quality of asthma management, knowledge about asthma and quality of life of asthma patients referred to a public tertiary care chest hospital in Delhi. METHODS: Diagnosis of asthma was confirmed by symptoms and reversible spirometry in 50 referred patients on their first visit. Patients were interviewed using three questionnaires on quality of asthma management before visiting referral hospital, asthma knowledge and asthma quality of life (AQLQ). Correlation amongst quality of treatment, asthma quality of life, and asthma knowledge was also determined. RESULTS: Findings revealed that only 60 per cent of patients were informed about their disease, and 10 per cent had undergone lung function tests previously. Only 44 per cent of patients were prescribed inhalers. None were provided with any educational material. Patients had poor knowledge of aetiology, pathophysiology, medication and how to assess the severity of their asthma. The mean scores in AQLQ indicated a moderate degree of impairment in quality of life. INTERPRETATIONS & CONCLUSIONS: This study provides evidence of unsatisfactory asthma management and patient-doctor interaction as patients had limited knowledge of asthma disease, its management and had poor quality of life as measured by a standardized questionnaire. Thus, there is need to implement suitable interventions to improve asthma management according to standard treatment guidelines in the community.


Subject(s)
Asthma/epidemiology , Asthma/therapy , Quality of Health Care , Urban Health Services , Adult , Asthma/diagnosis , Female , Humans , India , Male , Quality of Life , Spirometry , Surveys and Questionnaires
4.
J Clin Pharmacol ; 52(1): 6-17, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21415285

ABSTRACT

Persistent pain disorders are usually not adequately alleviated by nonsteroidal anti-inflammatory drugs or other simple analgesics. Use of antidepressants as adjuvant therapy for the control of persistent pain is currently being practiced in disorders such as fibromyalgia, neuropathic pain, rheumatoid conditions, low back pain, and headache. This review describes the various mechanisms of analgesic activity of antidepressants along with their efficacy and tolerability profiles. Meta-analyses and clinical studies of these agents were retrieved through the use of MEDLINE, Google scholar, and Cochrane databases. Antidepressants are effective in both neuropathic and non-neuropathic pain and have diverse mechanisms independent of their antidepressant effects. Tricyclic antidepressants (amitryptiline, nortryptiline, desipramine) are effective compounds in the treatment of neuropathic pain, fibromyalgia, low back pain, and headaches. Studies are ongoing for the dual serotonin norepinephrine reuptake inhibitors (duloxetine, venlafaxine) in several persistent pain conditions and these may be recommended in neuropathic pain, migraines, and fibromyalgia. Evidence suggests that although the analgesic effects of selective serotonin reuptake inhibitors (fluoxetine, paroxetine, citalopram) are limited and inconsistent, yet they have a superior tolerability profile compared with tricyclic antidepressants.


Subject(s)
Analgesics/therapeutic use , Antidepressive Agents/therapeutic use , Pain/drug therapy , Analgesics/adverse effects , Animals , Antidepressive Agents/adverse effects , Humans , Selective Serotonin Reuptake Inhibitors/adverse effects , Selective Serotonin Reuptake Inhibitors/therapeutic use
5.
Fundam Clin Pharmacol ; 25(2): 258-66, 2011 Apr.
Article in English | MEDLINE | ID: mdl-20584201

ABSTRACT

This study was conducted to determine the number and composition of the various cough and cold formulations available in the Indian market and to study their pharmacological rationale over a period of 7years. Data for the study was collected from an annual Drug Compendium entitled 'THE DRUG TODAY' of the years 2001, 2004, and 2007. Medications were assessed for total number, different formulations, and number of constituents present in each formulation, their pharmacological group and amount of each constituent per dose. Rationality of available preparations was assessed on a seven-point scoring criteria. There are over thirteen hundred drug products for cough and cold in the Indian market, which is an increase of 71.2% from the year 2001. More than 90% of the preparations were fixed-dose combinations (FDCs). Majority of the cough and cold preparations had 3-4 constituents. Many preparations contained more than one constituent of the same pharmacological group. Some preparations had constituents with opposing action. A wide variation in the amount of each constituent present per dose in different formulations was observed. The number of banned drug combinations for cough and cold showed an increase from 9 in 2001 to 27 in 2007. Rationality assessment of the FDC preparations revealed that most of the preparations were irrational and had no documented benefit in the treatment of common cold. Availability of such a large number of irrational FDCs for cough and cold requires serious review of the legal provisions in India for drug manufacturing and marketing.


Subject(s)
Common Cold/drug therapy , Cough/drug therapy , Nonprescription Drugs/administration & dosage , Drug Combinations , Humans , India , Nonprescription Drugs/supply & distribution , Nonprescription Drugs/therapeutic use
6.
Indian J Med Sci ; 64(6): 245-52, 2010 Jun.
Article in English | MEDLINE | ID: mdl-22885315

ABSTRACT

OBJECTIVES: To identify the adverse drug reactions (ADRs) to antiretroviral therapy (ART) and to assess their impact on treatment compliance in patients with HIV/AIDS. MATERIALS AND METHODS: Two hundred and thirty-five (235) AIDS patients who received ART were monitored for ADRs over a period of 6 months. The incidence and nature of ADRs occurring with different ART regimens were recorded. We also assessed the severity, causality as well as the impact of ADRs on the patients' compliance. RESULTS: Of 235 patients receiving ART, 90.6% patients experienced ADRs. A total of 618 ADRs involving various systems were observed. A majority were related to gastrointestinal (42.39%) and central nervous (25.57%) system. 23.1% ADRs were severe in intensity. Severe ADRs occurred in 41 out of 235 (17.4%) patients necessitating drug withdrawal. A majority of the patients (87.8%) who complained of severe ADRs received combination of stavudine, lamivudine and nevirapine. Causality assessment revealed 6.63% ADRs were probable and 93.3% ADRs were possible. Non-compliance due to ADRs was observed in 28.9% patients. CONCLUSIONS: Myriad ADRs are associated with ART which leads to poor patient compliance. With the increasing access to ART in India, it is prudent that antiretroviral drugs are used judicially with regular monitoring of ADRs.


Subject(s)
Acquired Immunodeficiency Syndrome/drug therapy , Anti-HIV Agents/adverse effects , Central Nervous System Diseases/chemically induced , Gastrointestinal Diseases/chemically induced , Adult , Drug Therapy, Combination/adverse effects , Female , Humans , India , Lamivudine/adverse effects , Male , Medication Adherence , Middle Aged , Nevirapine/adverse effects , Severity of Illness Index , Stavudine/adverse effects , Tertiary Care Centers
7.
Indian J Dent Res ; 20(4): 418-22, 2009.
Article in English | MEDLINE | ID: mdl-20139563

ABSTRACT

BACKGROUND: Non-steroidal antiinflammatory drugs (NSAIDs) are one of the most commonly prescribed drugs in clinical practice. Presently, several varieties of fixed dose combinations (FDCs) of NSAIDs are available over the counter and are being prescribed too. There is paucity of literature regarding comparative efficacy of these combinations against their individual component. Various clinical studies have documented increased incidence of gastric ulcerations with usage of more than one NSAID simultaneously. OBJECTIVES: To study gastric tolerability, antinociceptive and antiinflammatory activity of combination NSAIDs in rats. MATERIALS AND METHODS: Gastric tolerability of different NSAIDs was observed after administration of drugs for 7 days orally. On 7 th day, 4 h after drug administration, rats were sacrificed and stomach mucosa was examined for ulcerations. Analgesic or antinociceptive activity of single and combination NSAIDs was evaluated using Writhing test model. For induction of writhing, 4% normal saline (hypertonic saline) was injected (0.1 ml/10 gm) intraperitoneally. Evaluation of antiinflammatory activity for FDCs of NSAIDs was done by using rat paw edema model with the aid of plethysmometer. Paw edema was induced by injecting 0.1 ml of 1% formalin in sub-planter region of hind paw. RESULTS: Analgesic activity was found to be enhanced or significant only in the group pretreated with combination of nimesulide with ibuprofen as compared to ibuprofen-alone group (P = 0.01). Decrease in mean paw edema (antiinflammatory activity) was not significant in rats pretreated with combination NSAIDs as compared to NSAID-alone group. Mean gastric ulcer index was significant in groups pretreated with diclofenac alone (P = 0.03) and in combination groups of nimesulide with diclofenac and ibuprofen with paracetamol as compared to control (P = 0.03, P = 0.007). CONCLUSION: Addition of ibuprofen to paracetamol and combining diclofenac to nimesulide, significantly increased severity of gastric ulcerations. Fixed dose combination does not possess additional analgesic activity over their individual components, only exception being combination of nimesulide with ibuprofen, which has additional analgesic activity over ibuprofen alone, and this combination was not found to be ulcerogenic. Antiinflammatory activity of ibuprofen, paracetamol and nimesulide was significantly enhanced after addition of diclofenac.


Subject(s)
Analgesics, Non-Narcotic/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Gastric Mucosa/drug effects , Acetaminophen/administration & dosage , Acetaminophen/therapeutic use , Administration, Oral , Analgesics, Non-Narcotic/administration & dosage , Animals , Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Diclofenac/administration & dosage , Diclofenac/therapeutic use , Disease Models, Animal , Drug Combinations , Drug Evaluation, Preclinical , Edema/prevention & control , Ibuprofen/administration & dosage , Ibuprofen/therapeutic use , Pain/prevention & control , Rats , Rats, Wistar , Safety , Stomach Ulcer/chemically induced , Sulfonamides/administration & dosage , Sulfonamides/therapeutic use
8.
Indian Heart J ; 60(1): 69-72, 2008.
Article in English | MEDLINE | ID: mdl-19212031

ABSTRACT

Hypertension is one of the major causes of cardiovascular morbidity. Most patients who are on treatment for hypertension fail to achieve adequate control with the existing therapy and rates of cardiovascular morbidity remain high. As the renin-angiotensin-aldosterone system is strongly implicated in the development of hypertension-related target organ damage, intensive efforts have been devoted towards the development of drugs targeting this system. In addition to angiotensin converting enzyme inhibitors and angiotensin receptor blockers, inhibition of renin has also become a clinical reality. Aliskiren, a novel renin inhibitor, has overcome a number of shortcomings of existing drugs and is now available to address angiotensin production directly at its rate-limiting step.


Subject(s)
Amides/pharmacology , Fumarates/pharmacology , Hypertension/drug therapy , Renin/antagonists & inhibitors , Amides/chemistry , Amides/therapeutic use , Fumarates/chemistry , Fumarates/therapeutic use , Humans
9.
Indian J Psychiatry ; 50(1): 51-3, 2008 Jan.
Article in English | MEDLINE | ID: mdl-19771308

ABSTRACT

OBJECTIVE: To evaluate antidepressant-like effect of tramadol in mice. MATERIALS AND METHODS: Tramadol was administered at three different doses (10, 20, and 40 mg/kg, i.p.) once daily for 7 days to Swiss albino mice of either sex. The immobility period of control and drug-treated mice was recorded in forced swim test (FST). The antidepressant effect of tramadol was compared to that of fluoxetine (20 mg/kg, i.p.), administered for seven successive days. RESULTS: Tramadol produced significant antidepressant effect at all the three (10, 20, and 40 mg/kg) doses, as indicated by reduction in immobility times of drug-treated mice compared to control mice. The efficacy of tramadol at doses of 10 and 20 mg/kg was comparable to that of fluoxetine, but antidepressant activity in animals administered with tramadol 40 mg/kg was significantly less as compared to fluoxetine-pretreated mice. CONCLUSION: The results of the present study indicate antidepressant-like activity of tramadol.

10.
Indian J Pharmacol ; 40(3): 129-30, 2008 Jun.
Article in English | MEDLINE | ID: mdl-20040941

ABSTRACT

OBJECTIVE: To evaluate antidepressant like effect of tramadol in mice. MATERIALS AND METHODS: Tramadol was administered at three different doses (10,20 and 40 mg/kg, i.p) once daily for 7 days to Swiss albino mice of either sex. The immobility period of control and drug treated mice were recorded in tail suspension test (TST).The antidepressant effect of tramadol was compared to that of fluoxetine (20 mg/kg, i.p), administered for seven days. RESULTS: Tramadol produced significant antidepressant effect at all the doses, as indicated by reduction in immobility times as compared to control. The efficacy of tramadol at doses of 20 and 40 mg/kg was comparable with that of fluoxetine. Tramadol at 10 mg/kg dose showed significantly less antidepressant activity compared to fluoxetine. CONCLUSION: The results of the present study indicate antidepressant like activity of tramadol.

11.
Eur J Pharmacol ; 579(1-3): 1-12, 2008 Jan 28.
Article in English | MEDLINE | ID: mdl-18021769

ABSTRACT

Cytokines which comprise of a family of proteins--interleukins, lymphokines, monokines, interferons, and chemokines, are important components of the immune system. They act in concert with specific cytokine inhibitors and soluble cytokine receptors to regulate the human immune response. Their physiologic role in inflammation and pathologic role in systemic inflammatory states are now well recognized. An imbalance in cytokine production or cytokine receptor expression and/or dysregulation of a cytokine process contributes to various pathological disorders. Research is progressing rapidly in the area of cytokines and their therapeutic targets, the two major therapeutic modalities being the administration of purified recombinant cytokines and the use of their antagonists in various inflammatory disorders. However, given the large number of cytokines, it is disappointing that only relatively few can be used clinically. In the present article, we have made an attempt to review and present a glimpse of the history as well as up to date information that is pertinent to cytokines and anti-cytokine therapies in the treatment of cancer, autoimmune disorders and various other related diseases.


Subject(s)
Cytokines/therapeutic use , Immune System/drug effects , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Autoimmune Diseases/drug therapy , Autoimmune Diseases/physiopathology , Cytokines/pharmacology , Cytokines/physiology , Humans , Immune System/physiology , Interleukins/pharmacology , Interleukins/physiology , Interleukins/therapeutic use , Neoplasms/drug therapy , Neoplasms/physiopathology , Receptors, Chemokine/drug effects , Receptors, Chemokine/metabolism , Receptors, Interleukin-1/antagonists & inhibitors , Receptors, Interleukin-2/antagonists & inhibitors
12.
Indian J Exp Biol ; 45(12): 1031-6, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18254208

ABSTRACT

Antitubercular drug induced hepatotoxicity is a major hurdle for an effective treatment of tuberculosis. The present study was undertaken to assess the hepatoprotective potential of tocopherol (50 mg/kg and 100 mg/kg, ip) and to compare it with cimetidine (120 mg/kg, ip). Hepatotoxicity was produced by giving isoniazid (INH, 50 mg/kg, po) and rifampicin (RMP, 100 mg/kg, po) combination to albino rabbits for 7 days. Assessment of liver injury was done by estimating levels of alanine transaminase (ALT) and argininosuccinic acid lyase (ASAL) in serum and by histopathological examination of liver. Results revealed that pretreatment with high dose of tocopherol (100 mg/kg) prevented both biochemical as well as histopathological evidence of hepatic damage induced by INH and RMP combination. Moreover, tocopherol (100 mg/kg) was found to be a more effective hepatoprotective agent as compared to cimetidine.


Subject(s)
Antioxidants/physiology , Drug-Related Side Effects and Adverse Reactions/prevention & control , Liver Diseases , Tocopherols/pharmacology , Animals , Antioxidants/administration & dosage , Antitubercular Agents/toxicity , Chemical and Drug Induced Liver Injury , Cimetidine/pharmacology , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Isoniazid/toxicity , Liver Diseases/prevention & control , Rabbits , Rifampin/toxicity , Tocopherols/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...